Mobia Medical (NASDAQ:MOBI) Coverage Initiated by Analysts at Bank of America

Equities research analysts at Bank of America initiated coverage on shares of Mobia Medical (NASDAQ:MOBI) in a research report issued on Tuesday,Benzinga reports. The brokerage set a “buy” rating and a $16.00 price target on the stock. Bank of America‘s target price would indicate a potential upside of 18.52% from the company’s current price.

Several other research analysts have also recently issued reports on the company. Wall Street Zen raised Mobia Medical to a “hold” rating in a research report on Saturday, May 16th. The Goldman Sachs Group began coverage on Mobia Medical in a research note on Tuesday. They set a “buy” rating and a $31.00 target price for the company. Four research analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, Mobia Medical has an average rating of “Buy” and a consensus price target of $22.00.

Mobia Medical Trading Up 3.1%

Shares of NASDAQ MOBI opened at $13.50 on Tuesday. Mobia Medical has a 1-year low of $10.19 and a 1-year high of $14.04. The stock has a market cap of $446.65 million, a price-to-earnings ratio of 66.00 and a beta of 2.84.

Insider Activity

In other news, Director Dana G. Jr. Mead purchased 7,000 shares of the company’s stock in a transaction that occurred on Monday, May 11th. The shares were purchased at an average price of $15.00 per share, for a total transaction of $105,000.00. Following the purchase, the director directly owned 7,000 shares of the company’s stock, valued at $105,000. This represents a ∞ increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Cynthia L. Lucchese purchased 125,000 shares of the company’s stock in a transaction that occurred on Monday, May 11th. The shares were purchased at an average price of $15.00 per share, for a total transaction of $1,875,000.00. Following the purchase, the director directly owned 125,000 shares in the company, valued at $1,875,000. The trade was a ∞ increase in their ownership of the stock. The SEC filing for this purchase provides additional information. Insiders have bought a total of 1,268,332 shares of company stock worth $19,024,980 over the last ninety days.